Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-02-10
2010-11-02
Desai, Anand U (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S520000, C424S009322, C530S352000, C530S350000
Reexamination Certificate
active
07825083
ABSTRACT:
A composite tissue formed in situ is provided. The composite tissue includes a synovial joint tissue; and a barrier material adhered thereto for sealing the synovial joint tissue against synovial fluid. Also provided is a method for regenerating synovial joint tissue in situ by excluding synovial fluid therefrom. The method includes providing a synovial joint tissue having a defect; and placing a barrier material in intimate contact with the defect for sealing the defect against synovial fluid. The barrier material includes a curable protein copolymer. The method further includes curing the protein copolymer in situ. The barrier material can include a crosslinked network, or a self gelled network of repeating elastin-like and fibroin-like polymer chains.
REFERENCES:
patent: 4187852 (1980-02-01), Urry et al.
patent: 4589882 (1986-05-01), Urry
patent: 4595713 (1986-06-01), St. John
patent: 4898926 (1990-02-01), Urry
patent: 5064430 (1991-11-01), Urry
patent: 5235041 (1993-08-01), Cappello et al.
patent: 5243038 (1993-09-01), Ferrari et al.
patent: 5292362 (1994-03-01), Bass et al.
patent: 5336256 (1994-08-01), Urry
patent: 5374431 (1994-12-01), Pang et al.
patent: 5496712 (1996-03-01), Cappello et al.
patent: 5514581 (1996-05-01), Ferrari et al.
patent: 5770697 (1998-06-01), Ferrari et al.
patent: 5800544 (1998-09-01), Demopulos et al.
patent: 5817303 (1998-10-01), Stedronsky et al.
patent: 5853746 (1998-12-01), Hunziker
patent: 6018030 (2000-01-01), Ferrari et al.
patent: 6033654 (2000-03-01), Stedronsky et al.
patent: 6080192 (2000-06-01), Demopulos et al.
patent: 6080194 (2000-06-01), Pachence et al.
patent: 6106556 (2000-08-01), Demopulos et al.
patent: 6140072 (2000-10-01), Ferrari et al.
patent: 6184348 (2001-02-01), Ferrari et al.
patent: 6355776 (2002-03-01), Ferrari et al.
patent: 6376742 (2002-04-01), Zdrahala et al.
patent: 6380154 (2002-04-01), Cappello et al.
patent: 6403637 (2002-06-01), Partridge
patent: 6423333 (2002-07-01), Stedronsky et al.
patent: 6454811 (2002-09-01), Sherwood et al.
patent: 6458889 (2002-10-01), Trollsas et al.
patent: 6511511 (2003-01-01), Slivka et al.
patent: 6530956 (2003-03-01), Mansmann
patent: 6531147 (2003-03-01), Sawhney et al.
patent: 6630457 (2003-10-01), Aeschilmann et al.
patent: 6656925 (2003-12-01), Petrus
patent: 6835377 (2004-12-01), Goldberg et al.
patent: 7217294 (2007-05-01), Kusanagi et al.
patent: 7235074 (2007-06-01), Sklar
patent: 7252832 (2007-08-01), Stone et al.
patent: 2002/0082220 (2002-06-01), Hoemann et al.
patent: 2002/0119952 (2002-08-01), Petrus
patent: 2002/0122790 (2002-09-01), Hunziker
patent: 2002/0123805 (2002-09-01), Murray et al.
patent: 2002/0173855 (2002-11-01), Mansmann
patent: 2002/0187182 (2002-12-01), Kramer et al.
patent: 2003/0075822 (2003-04-01), Slivka et al.
patent: 2003/0104589 (2003-06-01), Stedronsky et al.
patent: 2003/0224989 (2003-12-01), Quinn et al.
patent: 2003/0235589 (2003-12-01), Demopulos et al.
patent: 2004/0059416 (2004-03-01), Murray et al.
patent: 2004/0228901 (2004-11-01), Trieu et al.
patent: 2005/0216014 (2005-09-01), May et al.
patent: 0 528 080 (1993-02-01), None
patent: 4334396 (1992-11-01), None
patent: WO 93/04711 (1993-03-01), None
patent: WO 94/01508 (1994-01-01), None
patent: WO 95/05396 (1995-02-01), None
patent: WO 96/34618 (1996-11-01), None
patent: WO 02/28417 (2002-04-01), None
Acharya et al. (2008) Silk fibroin protein from mulberry and non-mulberry silkworms: cytotoxicity, biocompatibility and kinetics of L929 murine fibroblast adhesion, J. Mater. Sci. Mater. Med., vol. 18, No. 8,pp. 2827-2836.
Friedel et al. (2005) Fabrication of polymer derived ceramic parts by selective laser curing, J. Eur. Ceram. Soc., vol. 25, pp. 193-197.
Convery et al.; The Repair of Large Osteochondral Defects; Clinical Orthopedics and Related Research vol. 82, pp. 253-262; 1972.
Knight et al.; Genetically Engineered, Enzymatically Crosslinked Elastinlike Polypeptide Gels for Cartilage Tissue Repair; Transactions of the Society for Biomaterials vol. 26, pp. 54, 2003.
Betre et al.; Genetically engineered Elastin-like Polypeptide Promotes Chondrocytic Differentiation of the Human Adipose Tissue-Derived Adult Stem Cells in Vitro; Transactions of the Orthopedic Research Society, vol. 29, pp. 158, 2004.
Fernandes et al.; The role of cytokines in osteoarthritis pathophysiology; Bioheology, vol. 39, Issue 1-2, pp. 237-246; 2002.
Sierra; Fibrin Sealant Adhesive Systems; A review of Their Chemistry, Material Properties and Clinical Applications; J. Biomat. App., vol. 7, pp. 309-352, 1993.
Bryant et al.; Controlling the spatial distribution of EMC components in degradable PEG hydrogels for tissue engineering cartilage; J. Biomed Res. vol. 64A, Issue 1, p. 70-79; Jan. 1, 2003.
Temenoff et al.; Effect of drying history on swelling properties and cell attachment to oligo(poly(ethylene glycol) fumarate) hydrogels for guided tissue regeneration applications; J. Biomater. Sci. Polym Ed.; vol. 14, Issue 9, pp. 989-1004; 2003.
Sims et al.; Injectable Cartilage Using Polyethylene Oxide Polymer Substrates; Plastic Reconstr. Surg., vol. 98, Issue 5, pp. 843-850; 1996.
Lee et al.; The effects of cross-linking of collagen-glycosaminoglycan scaffolds on compressive stiffness, chondrocyte-medicated contraction, proliferation and biosynthesis; Biomaterials, vol. 22, Issue 23, pp. 3145-2154; Dec. 2001.
Chenite et al.; Novel injectable neutral solutions of chitosan form biodegradable gels in situ; Biomaterials; vol. 21, issue 21, pp. 2155-2161; 2000.
Paige et al; Injectable Cartilage; Plast. Reconstr. Surg.; vol. 96; issue 6, pp. 1390-1398; Nov. 1995.
Nettles et al.; Photocrosslinkable Hyaluronan as a Scaffold for Articular Cartilage Repair; Ann Biomed Engin.; vol. 32, Issue 3, pp. 391-397; Mar. 2004.
Betre et al.; Characterization of a Genetically Engineered Elastin-like Polypeptide for Cartilaginous Tissue Repair; Biomacromolecules; vol. 3, issue 5, pp. 910-916; Sept.-Oct. 2002.
Hangody et al; MosaicPlasty™ Osteochondral Grafting Technique Guide, Arthroscopic Technique; Smith & Nephew, Inc. Copyright 1999 pp. 3-10.
Carticel: The Cost of this Alternative Therapy; http://biomed.brown.edu/Courses/BI108—1999—Groups/Cartilage—Team/matt/Carticel1.html; Dec. 30, 2004.
Genzyme Tissue Repair; http://arthroscopy.com/sp08001.htm; Dec. 30, 2004.
Gill et al.; The mechanism of the Microfracture Technique; http://www.sofarthro.com/ANNALES/ANNALES—1999/CARTILAGE/Microfracture.htm Oct. 19, 2004.
Cawston et al.; Mechanisms of Cartilage Breakdown and Repair; http://www.arc.org.uk/about—arth/med—reports/series3/tr/6415.htm; Dec. 30, 2004.
Desai Anand U
Hoffmann & Baron , LLP
Liu Samuel
Spine Wave, Inc.
LandOfFree
Synovial fluid barrier does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synovial fluid barrier, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synovial fluid barrier will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4153030